179 related articles for article (PubMed ID: 11356924)
1. Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells.
Kantor L; Hewlett GH; Park YH; Richardson-Burns SM; Mellon MJ; Gnegy ME
J Pharmacol Exp Ther; 2001 Jun; 297(3):1016-24. PubMed ID: 11356924
[TBL] [Abstract][Full Text] [Related]
2. Repeated amphetamine couples norepinephrine transporter and calcium channel activities in PC12 cells.
Kantor L; Zhang M; Guptaroy B; Park YH; Gnegy ME
J Pharmacol Exp Ther; 2004 Dec; 311(3):1044-51. PubMed ID: 15340003
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices.
Kantor L; Gnegy ME
J Pharmacol Exp Ther; 1998 Feb; 284(2):592-8. PubMed ID: 9454802
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.
Giambalvo CT
Synapse; 2003 Aug; 49(2):125-33. PubMed ID: 12740868
[TBL] [Abstract][Full Text] [Related]
5. Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells.
Apparsundaram S; Galli A; DeFelice LJ; Hartzell HC; Blakely RD
J Pharmacol Exp Ther; 1998 Nov; 287(2):733-43. PubMed ID: 9808704
[TBL] [Abstract][Full Text] [Related]
6. Modulation of amphetamine-stimulated [3H]dopamine release from rat pheochromocytoma (PC12) cells by sigma type 2 receptors.
Weatherspoon JK; Werling LL
J Pharmacol Exp Ther; 1999 Apr; 289(1):278-84. PubMed ID: 10087015
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms underlying the effects of amphetamine on particulate PKC activity.
Giambalvo CT
Synapse; 2004 Feb; 51(2):128-39. PubMed ID: 14618680
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine reduces vesicular dopamine content in dexamethasone-differentiated PC12 cells only following L-DOPA exposure.
Hondebrink L; Meulenbelt J; Timmerman JG; van den Berg M; Westerink RH
J Neurochem; 2009 Oct; 111(2):624-33. PubMed ID: 19702656
[TBL] [Abstract][Full Text] [Related]
9. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A
Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
[TBL] [Abstract][Full Text] [Related]
10. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins.
Apparsundaram S; Schroeter S; Giovanetti E; Blakely RD
J Pharmacol Exp Ther; 1998 Nov; 287(2):744-51. PubMed ID: 9808705
[TBL] [Abstract][Full Text] [Related]
11. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
Crespi D; Mennini T; Gobbi M
Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
[TBL] [Abstract][Full Text] [Related]
12. Involvement of calcium-mediated apoptotic signals in H2O2-induced MIN6N8a cell death.
Choi SE; Min SH; Shin HC; Kim HE; Jung MW; Kang Y
Eur J Pharmacol; 2006 Oct; 547(1-3):1-9. PubMed ID: 16934799
[TBL] [Abstract][Full Text] [Related]
13. Two distinct regulatory mechanisms of neurotransmitter release by phosphatidylinositol 3-kinase.
Itakura M; Yamamori S; Kuwahara R; Sekiguchi M; Takahashi M
J Neurochem; 2005 Jul; 94(2):502-9. PubMed ID: 15998300
[TBL] [Abstract][Full Text] [Related]
14. Enhanced dopamine release and phosphorylation of synapsin I and neuromodulin in striatal synaptosomes after repeated amphetamine.
Iwata SI; Hewlett GH; Ferrell ST; Kantor L; Gnegy ME
J Pharmacol Exp Ther; 1997 Dec; 283(3):1445-52. PubMed ID: 9400020
[TBL] [Abstract][Full Text] [Related]
15. Dopamine regulates cell cycle regulatory proteins via cAMP, Ca(2+)/PKC, MAPKs, and NF-kappaB in mouse embryonic stem cells.
Lee MY; Heo JS; Han HJ
J Cell Physiol; 2006 Aug; 208(2):399-406. PubMed ID: 16688761
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.
Wiesinger JA; Buwen JP; Cifelli CJ; Unger EL; Jones BC; Beard JL
J Neurochem; 2007 Jan; 100(1):167-79. PubMed ID: 17227437
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes.
Cowell RM; Kantor L; Hewlett GH; Frey KA; Gnegy ME
Eur J Pharmacol; 2000 Feb; 389(1):59-65. PubMed ID: 10686296
[TBL] [Abstract][Full Text] [Related]
18. Differential modulation of the glutamate transporters GLT1, GLAST and EAAC1 by docosahexaenoic acid.
Berry CB; Hayes D; Murphy A; Wiessner M; Rauen T; McBean GJ
Brain Res; 2005 Mar; 1037(1-2):123-33. PubMed ID: 15777760
[TBL] [Abstract][Full Text] [Related]
19. Pertussis toxin modification of PC12 cells lowers cytoskeletal F-actin and enhances norepinephrine secretion: involvement of protein kinase C and protein phosphatases.
Chen F; Wagner PD
Arch Physiol Biochem; 1998 Aug; 105(4):317-28. PubMed ID: 9711351
[TBL] [Abstract][Full Text] [Related]
20. Nicorandil, an adenosine triphosphate-sensitive potassium channel opener, inhibits muscarinic acetylcholine receptor-mediated activation of extracellular signal-regulated kinases in PC12 cells.
Niinomi K; Banno Y; Iida H; Dohi S
Anesth Analg; 2008 Dec; 107(6):1892-8. PubMed ID: 19020135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
